Gynecologic Oncology Reports (Apr 2022)

Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review

  • Yuki Karasawa,
  • Seiji Mabuchi,
  • Yuri Matsumoto,
  • Masahiko Umemoto,
  • Ayako Miyazaki,
  • Ayako Watanabe,
  • Ryoko Okura,
  • Risa Atsumi,
  • Kosuke Sakurai,
  • Takashi Shibuya,
  • Fuminori Kitada

Journal volume & issue
Vol. 40
p. 100938

Abstract

Read online

An arterioenteric fistula is a devastating and life-threatening condition. As patients often present in extremis from hemorrhage shock, an early diagnosis and prompt life-saving interventions have to be performed. In this report, we describe a case of a 38-year-old Japanese woman who presented with hematochezia that rapidly progressed to hemorrhagic shock secondary to an iliac artery-enteric fistula that developed during bevacizumab-containing chemotherapy for recurrent cervical cancer. The patient underwent successful endovascular treatment with a covered stent-graft as a bridge to definitive open surgery.

Keywords